Suivant

Lecture automatique

A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.

5 Vues • 07/10/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.

Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique